Latest News and Press Releases

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Europe Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "North America Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "European Association for the Study of Diabetes (EASD): Annual Meeting 2025 Highlights" report has been added to ResearchAndMarkets.com's offering.The...

Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The "Self-Monitoring Blood Glucose (Smbg) Devices Market Outlook 2025-2034: Market Share, and Growth Analysis" report has been added to ...

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian Bot, a renowned biopharmaceutical founder and...

Advances diabetes and obesity programs with icovamenib demonstrating durable 52-Week Phase II data and with BMF-650, Biomea’s next-generation, oral small molecule glucagon-like peptide-1 (“GLP-1”)...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering.The Japan Insulin Pen Market is forecasted to...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Insulin Pump Market Outlook 2025-2033" report has been added to ResearchAndMarkets.com's offering.The United States Insulin Pump Market...

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanism to induce central tolerance Lead program in Type...